Diabetes Management Market - (By Technology- Glucose Test Strips, Digital Health / Digital Therapeutics, Insulin Pumps, Continuous Glucose Monitoring (CGM), Insulin Pens, Side Effect Management And Diagnosis) - Global Industry Size, Share, Trends, and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 180

Introduction

Diabetes is a metabolic disease in which the blood sugar levels of the body is increased for extended period. During last few years, there is significant increase in the prevalence of the diabetes which has led to increase in the demand for the various types of technology for diabetes. This technology includes glucose test strips, digital health / digital therapeutics, insulin pumps, continuous glucose monitoring (CGM), insulin pens, side effect management and diagnosis. Digitalization and development in the technology has led to the introduction of the advanced devices. A number of companies are involved in the development of the advanced devices which are used in the management of the diabetes.

 Market Dynamics

During last decade there is a significant increase in the prevalence of the diabetes. As per the WHO, approximately 422 million people across the globe were suffering from diabetes in 2014 which is expected to increase in near future. Increasing prevalence of the diabetes is the major driving factor for the growth of the market. Obese and smokers are more prone to diabetes. Increasing patient suffering from obesity and changing lifestyle of the people has catalyzed the growth of the technology for diabetes management market. Moreover, increased the demand for the better treatment option, increasing per capita income, increasing government support, increasing healthcare expenditure, and development in the technology have boosted the growth of the market during the forecast period 2018—2026. However, lack of awakes among the people and limited availability of the skilled professionals are responsible for affecting the growth of the market negatively. In near future the market is expecting a healthy opportunity owing to the continuous increasing demand for the better technology.

Market Classification

The global technology for diabetes management market is majorly segmented into technology and region.

On the basis of technology, the market is segmented into glucose test strips, digital health / digital therapeutics, insulin pumps, continuous glucose monitoring (CGM), insulin pens, side effect management and diagnosis, and others.

Regional Overview

Regionally, the technology for diabetes management market is segmented into North America, Europe, Asia Pacific and Latin America, Middle East & Africa.

North America is expected to dominate the technology for diabetes management market owing to the presence of huge patient pool, advancement in technology, and high spending on healthcare. According to WHO, 9.2% of the American population were suffering from diabetes in 2015. Additionally, presence of a huge number of players and increasing government support will fuel the growth of the market. Europe accounts for the second leading market in the forecast period followed by the Asia Pacific. Presences of huge investment in European region, huge government support, and well developed economies have driven the growth of the European market.

Asia Pacific technology for diabetes management market expected to be the fastest growth during the forecast period of 2016—2026. The growth is majorly attributed due to presence of huge diabetic and obese patients of the region. According to the International Diabetes Federation (IDF), in 2016, approximately 60% of total global diabetic population was present in Asia of which over 114 million are in China alone. Moreover, increasing government support and increasing per capita income have fueled the growth of the Asia Pacific market. LAMEA region is expecting a steady growth during the forecast period 2018—2026.

Report Coverage

Market

Technology for Diabetes Management  Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

 Technology, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

 

Market Participants

Some of the major key players in the market are Abbott, Animas, DexCom, Medtronic, Roche, Accu-Chek, Eli Lilly, Bayer, LifeScan, Novo Nordisk, Sanofi-aventis, Merck, Takeda Pharmaceuticals, Novartis, and Bristol-Myers Squibb.

Market Segmentation

Market By Technology

  • Glucose Test Strips
  • Digital Health / Digital Therapeutics
  • Insulin Pumps
  • Continuous Glucose Monitoring (CGM)
  • Insulin Pens
  • Side Effect Management & Diagnosis
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

 


Related Reports

Wound Dressing Market (By Product - Traditional, Advanced [Moist, Foam, Alginate, Film, Hydrocolloid, Hydrogel], Antimicrobial [Silver, Non - Silver], Interactive [ Biomaterials, Skin - Substitute]) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction Moisture wound dressing is a clinical technique to create a moist around the wound in order to speed up the healing process and reduce scabs and scarring for beautiful skin. Moisture wound dressing promotes the growth and migration of new cells and also maintains the proteins that are essential for wound closure. The report provides analysis of global moisture wound

Infection Surveillance Solutions Market (By Product and Services - Software [ On-premise, Web-based], Services; By Infection Type - Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Others; By End-use - Long Term Care Facilities, Hospitals, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction    Healthcare associated Infections (HAIs), or nosocomial contaminations, are the measure of the patient prosperity and health concerns coming about because of poor cleanliness, diminished patient immunity, carelessness and extra medicinal services uses. Infection surveillance is designed to constantly monito

Hematology Diagnostics Market (By Product - Instrument [Analyzers, Flow Cytometers, Others], Consumables, Reagents, Stains, Others; By Test Type - Blood Count, Platelet function, Hemoglobin, Hematocrit; By End Use - Hospitals, Diagnostic Labs, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction Hematology is a part of drug, which manages the study of blood, blood illnesses and blood-forming organs. Hematology incorporates issues related with white platelets, red platelets, bone marrow, lymph, and platelets. It additionally influences the fluid part of blood known as plasma. Hematology incorporates different IVD advancements, such as blood analysis, stream

Healthcare Contract Research Organization (CRO) Market (By Product - Drug Discovery, Pre-Clinical, Clinical; By Service - Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/ Assurance, Bio-statistics, Investigator Payments, Laboratory, Patient and site Recruitment, Technology, Others) Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction    Healthcare contract research organization (CRO) provides support and services as biologic assay development, clinical research, commercialization, preclinical research, clinical trials management and biopharmaceutical development to biotechnology, pharmaceutical and medical device industries. Healthcare co

Antibiotic Resistance Market (By Disease - cUTI, cIAI, BSI, CDI, ABSSSI, HABP/VABP, CABP; By Pathogen - Acinetobacter Baumannii, Pseudomonas Aeruginosa, Staphylococcus Aureus, E. coli/K. Pneumoniae, Streptococcus Pneumoniae, Clostridium difficile, Enterococcus faecium, Haemophilus Influenzae; By Drug Class - Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination therapies, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction    Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause

Sterility Indicators Market (By Type - Chemical Indicators, Biological Indicators; By Technique - Heat Sterilization, Low Temperature Sterilization, Filtration, Sterilization, Radiation Sterilization, Liquid Sterilization; By End-user - Hospitals, Pharmaceutical Companies, Medical device Companies, Clinical, laboratories/Research Centers, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction The global sterility indicators market was valued at USD 547.5 million in 2017 in terms of revenue. It is expected to grow at a CAGR of 10.8% during the forecast period. Stringent regulations regarding healthcare products and greater emphasis on sterility parameters and methods for the prevention of Hospital Acquired Infections are anticipated to dr

Cart Summary